1291 related articles for article (PubMed ID: 17324399)
21. N-Methyl-D-aspartate receptor antagonism decreases motility and inflammatory activation in the early phase of acute experimental colitis in the rat.
Varga G; Erces D; Fazekas B; Fülöp M; Kovács T; Kaszaki J; Fülöp F; Vécsei L; Boros M
Neurogastroenterol Motil; 2010 Feb; 22(2):217-25, e68. PubMed ID: 19735360
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic effects of rectal administration of muscovite on experimental colitis in rats.
Chen Y; Chen Y; Liu WL; Zhou TH; Cai JT; Du Q; Wang LJ; Wu JG; Si JM
J Gastroenterol Hepatol; 2009 May; 24(5):912-9. PubMed ID: 19220658
[TBL] [Abstract][Full Text] [Related]
23. A protective effect of the synthetic coumarine derivative Cloricromene against DNB-colitis in the rat.
Fries W; Mazzon E; Sturiale S; Giofré MR; Lo Presti MA; Cuzzocrea S; Campo GM; Caputi AP; Longo G; Sturniolo GC
Life Sci; 2004 Apr; 74(22):2749-56. PubMed ID: 15043989
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-1beta targets interleukin-6 in progressing dextran sulfate sodium-induced experimental colitis.
Kwon KH; Murakami A; Hayashi R; Ohigashi H
Biochem Biophys Res Commun; 2005 Nov; 337(2):647-54. PubMed ID: 16202978
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic effect and mechanism of proanthocyanidins from grape seeds in rats with TNBS-induced ulcerative colitis.
Li XL; Cai YQ; Qin H; Wu YJ
Can J Physiol Pharmacol; 2008 Dec; 86(12):841-9. PubMed ID: 19088805
[TBL] [Abstract][Full Text] [Related]
26. Granisetron ameliorates acetic acid-induced colitis in rats.
Fakhfouri G; Rahimian R; Daneshmand A; Bahremand A; Rasouli MR; Dehpour AR; Mehr SE; Mousavizadeh K
Hum Exp Toxicol; 2010 Apr; 29(4):321-8. PubMed ID: 20154102
[TBL] [Abstract][Full Text] [Related]
27. Effect of Astragalus polysaccharides on expression of TNF-α, IL-1β and NFATc4 in a rat model of experimental colitis.
Yang M; Lin HB; Gong S; Chen PY; Geng LL; Zeng YM; Li DY
Cytokine; 2014 Dec; 70(2):81-6. PubMed ID: 25132256
[TBL] [Abstract][Full Text] [Related]
28. Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.
Stosic-Grujicic S; Stojanovic I; Maksimovic-Ivanic D; Momcilovic M; Popadic D; Harhaji L; Miljkovic D; Metz C; Mangano K; Papaccio G; Al-Abed Y; Nicoletti F
J Cell Physiol; 2008 Jun; 215(3):665-75. PubMed ID: 18064633
[TBL] [Abstract][Full Text] [Related]
29. Acute and chronic responses associated with adrenomedullin administration in experimental colitis.
Talero E; Sánchez-Fidalgo S; de la Lastra CA; Illanes M; Calvo JR; Motilva V
Peptides; 2008 Nov; 29(11):2001-12. PubMed ID: 18708104
[TBL] [Abstract][Full Text] [Related]
30. The effect of the cholinergic anti-inflammatory pathway on experimental colitis.
Bai A; Guo Y; Lu N
Scand J Immunol; 2007 Nov; 66(5):538-45. PubMed ID: 17953529
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of thalidomide on trinitrobenzene sulfonate-induced colitis in young rats and its mechanism.
Xu J; Zheng C; Huang Y; Liang Y
Chin Med J (Engl); 2014; 127(12):2368-75. PubMed ID: 24931258
[TBL] [Abstract][Full Text] [Related]
32. Transgenic over-expression of macrophage migration inhibitory factor renders mice markedly more susceptible to experimental colitis.
Ohkawara T; Miyashita K; Nishihira J; Mitsuyama K; Takeda H; Kato M; Kondo N; Yamasaki Y; Sata M; Yoshiki T; Sugiyama T; Asaka M
Clin Exp Immunol; 2005 May; 140(2):241-8. PubMed ID: 15807847
[TBL] [Abstract][Full Text] [Related]
33. Effects of statins on experimental colitis in normocholesterolemic rats.
Jahovic N; Gedik N; Ercan F; Sirvanci S; Yüksel M; Sener G; Alican I
Scand J Gastroenterol; 2006 Aug; 41(8):954-62. PubMed ID: 16803694
[TBL] [Abstract][Full Text] [Related]
34. Infliximab modifies mesenteric adipose tissue alterations and intestinal inflammation in rats with TNBS-induced colitis.
Clemente TR; Dos Santos AN; Sturaro JN; Gotardo EM; de Oliveira CC; Acedo SC; Caria CR; Pedrazzoli J; Ribeiro ML; Gambero A
Scand J Gastroenterol; 2012 Sep; 47(8-9):943-50. PubMed ID: 22630819
[TBL] [Abstract][Full Text] [Related]
35. Role of TNF-alpha in muscularis inflammation and motility disorder in a TNBS-induced colitis model: clues from TNF-alpha-deficient mice.
Kinoshita K; Hori M; Fujisawa M; Sato K; Ohama T; Momotani E; Ozaki H
Neurogastroenterol Motil; 2006 Jul; 18(7):578-88. PubMed ID: 16771773
[TBL] [Abstract][Full Text] [Related]
36. A traditional Japanese medicine mitigates TNBS-induced colitis in rats.
Fukuda Y; Tao Y; Tomita T; Hori K; Fukunaga K; Noguchi T; Hayashi T; Shimoyama T; Tahahashi R
Scand J Gastroenterol; 2006 Oct; 41(10):1183-9. PubMed ID: 16990203
[TBL] [Abstract][Full Text] [Related]
37. Influence of simultaneous inhibition of cyclooxygenase-2 and inducible nitric oxide synthase in experimental colitis in rats.
Dudhgaonkar SP; Tandan SK; Kumar D; Raviprakash V; Kataria M
Inflammopharmacology; 2007 Oct; 15(5):188-95. PubMed ID: 17943250
[TBL] [Abstract][Full Text] [Related]
38. Lactic acid bacteria inhibit proinflammatory cytokine expression and bacterial glycosaminoglycan degradation activity in dextran sulfate sodium-induced colitic mice.
Lee HS; Han SY; Bae EA; Huh CS; Ahn YT; Lee JH; Kim DH
Int Immunopharmacol; 2008 Apr; 8(4):574-80. PubMed ID: 18328449
[TBL] [Abstract][Full Text] [Related]
39. Curcumin regulated shift from Th1 to Th2 in trinitrobenzene sulphonic acid-induced chronic colitis.
Zhang M; Deng CS; Zheng JJ; Xia J
Acta Pharmacol Sin; 2006 Aug; 27(8):1071-7. PubMed ID: 16867261
[TBL] [Abstract][Full Text] [Related]
40. Teupolioside, a phenylpropanoid glycosides of Ajuga reptans, biotechnologically produced by IRBN22 plant cell line, exerts beneficial effects on a rodent model of colitis.
Di Paola R; Esposito E; Mazzon E; Riccardi L; Caminiti R; Dal Toso R; Pressi G; Cuzzocrea S
Biochem Pharmacol; 2009 Mar; 77(5):845-57. PubMed ID: 19070602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
